Evidence map›Paper›PMID 32765190›Full record

ReviewClinical and molecular allergy : CMA2020

SIRM-SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media.

Maria Teresa Costantino, Laura Romanini, Francesco Gaeta, Fulvio Stacul, Rocco Luigi Valluzzi, Matteo Passamonti, Patrizia Bonadonna, Giovanni Cerri, Stefano Pucci, Paolo Ricci and 14 more

Erratum issuedAbstract readReview
In one paragraph

Review in Clinical and molecular allergy : CMA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Maria Teresa Costantino *Allergy Unit, Department of Medicine, ASST Mantova, Mantua, Italy.
Laura Romanini *Radiology, Istituti Ospitalieri di Cremona, ASST Cremona, Cremona, Italy.
Francesco Gaeta *Allergy Unit, Columbus Hospital, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Via Moscati n.30, Rome, Italy.ORCID 0000-0003-2942-7633
Fulvio Stacul *Department of Radiology, Ospedale Maggiore, Azienda Sanitaria Universitaria Integrata di Trieste, Trieste, Italy.
Rocco Luigi Valluzzi *Allergy Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Vatican City, Italy.
Matteo Passamonti *Department of Radiology-ASST di Lodi, Lodi, Italy.
Patrizia BonadonnaAllergy Unit, Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
Giovanni CerriDepartment of Radiology, ASST Spedali Civili di Brescia, Brescia, Italy.
Stefano PucciAllergy Unit. General Hospital, Civitanova Marche, Milan, Italy.
Paolo RicciDepartment of Radiology, Oncologiche ad Anatomopatologiche, Azienda Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy.
Eleonora SaviDepartmental Unit of Allergology, Guglielmo da Saliceto Hospital, Piacenza, Italy.
Michele GalluzzoDepartment of Radiology, Azienda Ospedaliera San Camillo Forlanini, Ospedale San Camillo, Rome, Italy.
Marina MauroAllergy Unit, S. Anna Hospital, Como, Italy.
Emanuele GrassedonioDepartment of Radiology, Dipartimento di Biopatologia e Biotecnologie Mediche, Policlinico Paolo Giaccone, Università degli Studi di Palermo, Palermo, Italy.
Mona Rita YacoubAllergy and Immunology Department, IRCCS San Raffaele Hospital, Milan, Italy.
Alfonso ReginelliDepartment of Radiology & Radiotherapy, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Sergio TestiAllergy and Clinical Immunology Unit, San Giovanni di Dio's Hospital, Florence, Italy.
Erminia RidoloDepartment of Medicine and Surgery Clinical, University of Parma, Via Gramsci 14, 43126 Parma, Italy.
Eustacchio NettisDepartment of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Bari, Italy.
Elisabetta Di LeoSection of Allergy and Clinical Immunology, Unit of Internal Medicine, "F. Miulli" Hospital, Acquaviva delle Fonti, Bari, Italy.
Oliviero RossiAllergy Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
Paolo MontuschiPharmacology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Cristoforo IncorvaiaCardiac/Pulmonary Rehabilitation, ASST Pini-CTO, Milan, Italy.
Antonino RomanoIRCCS Oasi Maria S.S., Troina & Fondazione Mediterranea G.B. Morgagni, Catania, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypersensitivity reactions (HRs) to contrast media (CM) can be distinguished in immune-mediated (including allergic reactions) and non-immune-mediated reactions, even if clinical manifestations could be similar. Such manifestations range from mild skin eruptions to severe anaphylaxis, making it important for radiologists to know how to identify and manage them. A panel of experts from the Società Italiana di Radiologia Medica e Interventistica (SIRM) and the Società Italiana di Allergologia, Asma e Immunologia Clinica (SIAAIC) provided a consensus document on the management of patients who must undergo radiological investigations with CM. Consensus topics included: the risk stratification of patients, the identification of the culprit CM and of a safe alternative by an allergy workup, as well as the use of premedication and the correct procedure to safely perform an elective (i.e., scheduled) or urgent examination. The most important recommendations are: (1) in all patients, a thorough medical history must be taken by the prescribing physician and/or the radiologist to identify at-risk patients; (2) in patients with hypersensitivity reactions to CM, the radiologist must consider an alternative, non-contrast imaging study with a comparable diagnostic value, or prescribe a different investigation with another class of CM; (3) if such options are not feasible, the radiologist must address at-risk patients to a reference centre for an allergy evaluation; (4) if timely referral to an allergist is not viable, it is recommended to use a CM other than the responsible one, taking into account cross-reactivity patterns; in the case of patients with histories of severe reactions, the presence of an anesthesiologist is also recommended and a premedication is suggested.

Indexed as

DiagnosisHypersensitivity reactionsLow-osmolar contrast agentsManagementRadiologic contrast media

Identifiers

PMID32765190
PMCPMC7395340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.